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Macroscopic fi ndings in collagenous colitis: a multi-center, 
retrospective, observational cohort study
Anastasios Koulaouzidisa, Diana E. Yunga, Artur Nemethb, Klas Sjöbergc, Andry Giannakoue, 
Raheel Qureshif, Leonidas Bartzisa, Morna McNeilld, Gabriele Wurm Johanssonb, Alfredo J. Lucendog, 
Paul Finerond, Ken C. Trimblea, Athar Saeedf, John N. Plevrisa, Ervin Tothb
Th e Royal Infi rmary of Edinburgh, Edinburgh, Scotland, UK; Skåne University Hospital, Malmö, Sweden; Western 
General Hospital, Edinburgh, Scotland, UK; Open University of Cyprus, Nicosia, Cyprus; Queen Elizabeth Hospital, 
Gateshead, England, UK; Hospital General de Tomelloso, Spain
Abstract Background Collagenous colitis (CC) is by defi nition a histological diagnosis. However, 
colonoscopy oft en reveals characteristic endoscopic fi ndings. Th e aim of this study was to evaluate 
the frequency and type of endoscopic fi ndings in patients diagnosed with CC in 4 participating 
centers.
Methods Th is was a retrospective study; the databases of 2 university hospitals in Edinburgh 
(Scotland) and Malmö (Sweden), and 2 district general hospitals in Tomelloso (Spain) and 
Gateshead (England) were interrogated for patients diagnosed with CC between May 2008 
and August 2013. Endoscopy reports and images were retrieved and reviewed; data on lesions, 
sedation, bowel preparation and endoscopist experience were abstracted. Categorical data are 
reported as mean±SD. Fischer’s exact, chi-square and t (unpaired) tests were used to compare 
datasets. A two-tailed P-value of <0.05 was considered statistically signifi cant.
Results 607  patients (149  male, mean age 66.9±12.25  years) were diagnosed with CC. A  total 
of 108/607  (17.8%) patients had one or more suggestive endoscopy fi ndings: i.e.,  mucosal 
erythema/edema, 91/607  (15%); linear colonic mucosal defects, 12/607  (2%); or mucosal 
scarring, 5/607  (0.82%). For colonic mucosa erythema, there was no diff erence in the odds of 
fi nding erythema with the use of diff erent bowel preparation methods (P=0.997). For colonic 
mucosal defects there was some evidence (P=0.005) that patients colonoscoped by experienced 
endoscopists had 87% less odds of developing such defects. Moreover, there was evidence that 
analgesia reduced the odds of developing mucosal defects by 84%.
Conclusion A signifi cant minority of patients with CC have endoscopic fi ndings in colonoscopy. 
Th e description of such fi ndings appears to be related to the endoscopist’s experience.
Keywords Microscopic colitis, colonoscopy, macroscopic fi ndings, endoscopist training, 
observational study
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Introduction
Microscopic colitis (MC) is diagnosed in approx. 10% of 
patients investigated for chronic, non-bloody diarrhea and 
its etiology remains by and large uncertain [1]. However, the 
term “microscopic” should not be encouraged, as it can restrict 
the endoscopist’s diagnostic acumen [2]. Collagenous colitis 
(CC) was independently described by Lindstrom (Sweden) 
and Freeman (Canada) in the late 1970s [3]; it is one of the 
2 main subtypes of MC [1,4]. In 2011, we systematically 
reviewed the published papers on the endoscopic fi ndings 
in CC [5]. We recommended the following types of distinct 
endoscopic fi ndings in CC, with the following visual 
vocabulary: 1) pseudomembranes; 2) alteration of the vascular 
submucosal pattern, such as an indistinct appearance of the 
blood vessels with a variable degree of vasculature pruning, or 
a crowded, dilated and tortuous capillary network; 3) mucosal 
abnormalities such as erythema and/or edema/nodularity, 
or surface textural alteration (evident with or without 
chromoendoscopy); 4) a continuum of mucosal defects, 
i.e.,  mucosal lacerations/tears, including the so-called “cat-
scratch colon” pattern, or fractures usually along the long axis 
of the colon; and 5) fi ne, linear cicatricial lines or thick scar-
like ridges of the mucosal surface (eff ects of the healing process 
of mucosal defects) (Fig. 1 A-E) [5].
However, the reporting of such endoscopic abnormalities 
remains inconsistent and dependent on local expertise, 
specialist interest and awareness of the aforementioned 
endoscopic “visual vocabulary” [6]. Given the ever-increasing 
workload of modern endoscopy units, recognizing CC on 
endoscopy has the potential to improve the diagnosis and 
management of this common disorder [7]. Th erefore, the 
aim of the present study was to confi rm the presence of these 
characteristic macroscopic fi ndings in the largest retrospective 
cohort to date. Th e secondary aim was to explore the correlation 
of these fi ndings with the presenting symptoms, the experience 
of the endoscopist, the type of bowel purge used and the use of 
spasmolytics and/or analgesics during the procedure.
Patients and methods
Th is is an international, retrospective, observational cohort 
report of the recorded colonoscopy fi ndings in patients who 
underwent colonoscopy for the investigation of diarrhea, with 
or without “plus symptoms”, and were eventually diagnosed 
with CC in four participating centers: two University Hospitals 
(Th e Royal Infi rmary of Edinburgh, Scotland, UK and the 
Skåne University Hospital, Malmö, Sweden), and 2 district 
general hospitals (Queen Elizabeth Hospital, Gateshead, 
England and the Hospital General de Tomelloso, Spain). 
“Plus symptoms” were defi ned as weight loss, abdominal pain, 
bloating, fatigue, anemia and/or elevated fecal calprotectin. 
Colonoscopes used were Olympus and Fujinon models, 
depending on the usual practice in each participating center.
Data were collected from the histopathology registry of the 
four participating centers. All patients with a histopathological 
diagnosis of CC between 2008 and 2013 were included. 
Th e hospital case notes were reviewed, and information on 
patients’ sex, age, colonoscopy indication(s), experience of 
the endoscopist (non-training grades: i.e.,  senior medical 
or surgical staff , including consultants/specialists/nurse 
practitioners or trainees), sedation/analgesia/spasmolytics 
Figure 1 (A) Alteration of the vascular submucosal pattern; indistinct appearance of the blood vessels with a variable degree of vasculature pruning. 
(B) Mucosal edema/nodularity, evident without chromoendoscopy. (C) Mucosal edema/nodularity, evident with chromoendoscopy. (D) Mucosal 
lacerations/tears, including the so-called “cat-scratch colon” pattern. (E) Fine, linear cicatricial lines of the mucosal surface (eff ects of the mucosal 
healing process of mucosal defects)
D
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(hyoscine or glucagon) administered during the colonoscopy, 
type of bowel preparation used (polyethylene glycol [PEG] 
or sodium picosulphate [SP]), and outcome eff ect of bowel 
preparation (good, satisfactory, poor) was extracted. In 
addition, the endoscopic fi ndings for each case were abstracted.
Th e classifi cation of endoscopy fi ndings was based on 
that suggested by Koulaouzidis and Saeed [5]. Th e criteria to 
diagnose CC were a relevant clinical history, i.e.,  protracted 
(>3  weeks) watery diarrhea, in conjunction with distinctive 
histopathological features, i.e.,  a sub-epithelial collagen 
band ≥10 μm in thickness in comparison with a normal 
basal membrane of <3 μm. Th e surface epithelium may 
show vacuolization, fl attening, mucin depletion, and focal 
detachment from the basement membrane [7]. An increase 
in intraepithelial lymphocytes was not considered a necessary 
criterion for the diagnosis of CC.
Th is study was conducted in accordance with international 
research ethics guidelines. Aft er review by each local ethics 
committee, further specifi c ethical review and approval were 
not required, as the study was considered to be an evaluation 
of previously collected data, obtained as part of regular clinical 
care.
Statistical analysis
Continuous variables are reported as mean  ±  standard 
deviation (SD). Th e chi-square test was used to test for 
statistically signifi cant diff erences between two or more 
groups, with a P-value of <0.05 considered signifi cant. Where 
a statistically signifi cant diff erence was found between more 
than 2 groups, post-hoc analysis was carried out in an attempt 
to fi nd the source of the diff erence.
Logistic regression analysis was used for the correlation of 
colonoscopy fi ndings: mucosal erythema, edema, cat-scratch 
colon, mucosal defects (lacerations/tears/fractures), and 
mucosal scars. Th e initial model contained a combination of 
type of laxative preparation, outcomes of bowel preparation, 
symptoms (diarrhea or diarrhea plus symptoms), endoscopist’s 
experience, and the use of midazolam, Entonox, spasmolytics 
(hyoscine butylbromide/glucagon), analgesics (morphine/
pethidine/fentanyl) and propofol as potential predictors. Each 
initial model was subjected to a variable selection procedure 
using the method of backwards elimination on 200 bootstrap 
samples drawn from the sample, i.e.,  the complete data. Th e 
bootstrap samples were of the same size as the complete data 
(n=276).
Results
During the study period, a total of 607 patients (149 men/458 
women; mean age 66.9±12.25 years) were diagnosed with CC 
at the 4 participating centers. Th e full range of endoscopic 
fi ndings identifi ed is shown in Fig. 1 B-E. Th e demographics 
and test indications are shown in Table 1. Th e colonoscopies 
were carried out by senior medical or surgical endoscopists 
in 461 (76%) patients. A total of 108/607 (17.8%) patients had 
one or more of the endoscopy fi ndings previously described as 
being suggestive of CC in endoscopy: i.e., mucosal erythema/
edema (mosaic pattern), 91/607 (15%); linear colonic mucosal 
defects (lacerations/tears/fractures/cat-scratch mucosa), 
12/607 (2%); or cicatricial mucosal lesions, 5/607 (0.82%).
• For colonic mucosa erythema, there was no diff erence 
in the odds of fi nding erythema when colonic purge was 
performed with SP compared to PEG (P=0.997). However, 
when the colonoscopy indication was diarrhea plus 
symptoms, the odds of identifying mucosal erythema were 
3.22  times greater than when the sole indication for the 
procedure was diarrhea alone.
• For colonic mucosal defects (lacerations/tears/fractures), 
there was weak evidence (P=0.097) that patients with 
diarrhea alone had 70% less chance of developing 
mucosal defects (lacerations/tears and mucosal fractures). 
Furthermore, there was some evidence (P=0.005) that 
patients colonoscoped by an experienced endoscopist had 
87% lower odds of developing colonic mucosal defects than 
when colonoscoped by a nurse practitioner or a trainee 
endoscopist. Moreover, there was evidence that the use of 
analgesics (in particular morphine) reduced the odds of 
developing mucosal defects by 84%.
• For colonic mucosal scars and cat-scratch colon, there was 
insuffi  cient data to detect an eff ect by any of the variables 
(Table 2).
Th ere was no reported perforation in either group, 
i.e.,  those with and without macroscopic fi ndings. Table  3 
shows a comparison of patient characteristics between the 4 
participating centers, refl ecting diff erences in local practice 
and protocols.
Discussion
Epidemiologic studies show that MC is almost as common 
as classic infl ammatory bowel disease [1], with incidence rates 
(for CC) of 2.6-10.8/100,000 [1,4,6,8]. MC may be diagnosed 
in up to 10% of patients investigated for refractory watery 
diarrhea [1,9]. A  recent study found that endoscopists in 
academic practice, compared to those working in a private 
practice setting, were more likely to make an endoscopic 
diagnosis of MC, possibly due to enhanced diligence, backed 
Table 1 Clinical characteristics of patients with collagenous colitis
Number of cases
Men/women 149/458
Age (years±SD) 66.9±12.25
Indications
Diarrhea only 466
Diarrhea plus other symptoms 85
Not available 19
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Table 2 Odds ratio of the macroscopic fi ndings per factor examined
 OR SE 95% CI P-value
Mucosal erythema
(Intercept) 0.25 1.118 0.164-0.381 0.215
Phosphate enema 0.50 1.541 0.139-1.798 0.653
Sodium picosulphate 0.12 1.24 0.1-0.142 0.08
Polyethylene glycol 1.0 1.143 0.141-7.02 0.997
Diarrhea plus symptoms (weight loss, abdominal pain, others) 3.22 0.508 3.092-3.362 0.021
Mucosal defects (lacerations/tears and mucosal fractures)
(Intercept) 1.00 0.8158 0.202-4.943 0.9991
Diarrhea only 0.30 0.7273 0.072-1.244 0.0969
Trainee/nurse endoscopist 0.13 0.7341 0.030-0.537 0.005
Analgesic use 0.16 0.7136 0.039-0.638 0.0096
Mucosal scars (n=4)
(Intercept) 0.02 1.01 0.002-0.136 0.0001
Diarrhea only 0.28 1.42 0.017-4.558 0.371
OR, odds ratio; SE, standard error; CI, confidence interval
by pattern recognition, in taking colonic biopsies when 
investigating altered bowel habits [7]. Interestingly, it was 
the endoscopists with lower annual endoscopy volumes and 
physicians with a medical gastroenterology background, 
compared to surgical endoscopists, who had the highest 
diagnostic yield for MC [7]. Th is probably refl ects limitations 
associated with time constraints in off ering service-oriented 
endoscopy in busy units, as well as possible positive awareness 
bias at more academic-oriented units. In our study, there 
was no statistically signifi cant diff erence in the proportion of 
patients with endoscopic fi ndings when university and district 
hospitals were compared; however, it must be noted that 
awareness of MC is relatively high at all centers in this study.
For a long time it has been a matter of debate as to what 
drives the rising incidence of MC, and a recent study identifi ed 
that recognition of the disease and the practice setting of 
the endoscopists and pathologists involved may be major 
factors [6]. Dissemination of relevant guidelines has led to an 
increase in taking biopsies in the appropriate setting; this may 
have led to the epiphenomenon of increased incidence [6,9]. 
However, the very term MC was coined to group the 2 colitides 
that are considered to present with typical clinical symptoms of 
chronic watery, non-bloody, and refractory diarrhea, but little 
in the way of macroscopic fi ndings during colonoscopy [1,2].
Recently, the functionality of this term has been questioned 
on several occasions, especially with the advent of new, high 
defi nition endoscopes, with or without the application of 
chromoendoscopy or endomicroscopy [2,5,10-12]. Although 
there is no feature that could be seen as truly pathognomonic 
of MC, or CC specifi cally, on colonoscopy, linear mucosal 
defects [5] or fractures of the colon mucosa have a higher 
sensitivity and specifi city than cat-scratch colon, mucosal 
cobblestone or subtle changes of the surface mucosa 
vasculature [5,10,11,13-16]. Nevertheless, the offi  cial statement 
of the European Microscopic Colitis Group considers that 
colonoscopy is ‘normal or near-normal’ [1].
Th e Edinburgh experience shows that a signifi cant 
minority of patients who are eventually diagnosed with 
CC [17] have one or more of the fi ndings that have been 
described as (endoscopically) suggestive of MC [5]. Colonic 
perforation has been described in CC and remains a serious 
concern, especially when deep mucosal tears appear [15,18]. 
Mucosal tears/fractures are dramatic endoscopic fi ndings, 
and hence unlikely to be missed. In our multi-center cohort, 
no endoscopic perforation occurred following colonoscopy 
and biopsy. Furthermore, there was no diff erence in the 
reporting of macroscopic fi ndings between the participating 
centers (P=0.9), although awareness levels were high in all 
participating units.
Th e fact that the prevalence of mucosal lacerations is higher 
in the non-analgesia group may refl ect the need for more 
aggressive air distension for further scope insertion, due to 
a cycle of discomfort, agitation, and endoscopist stress. Th is 
could result in more radial distension of the colon and the lack 
of compliance causes detachment of the mucosa from deeper 
submucosal layers, especially during bowel wall stretching, 
with air insuffl  ation on colonoscopy or even spontaneously 
during defecation [19].
Th ere are, of course, certain limitations to this study, 
stemming from its retrospective nature and therefore the lack 
of a control group, potential heterogeneity of the endoscopic/
histological fi ndings and reporting criteria, the use of diff erent 
type of analgesics and of diff erent colonoscope models. 
Furthermore, recall bias is to be expected, as senior physicians 
were aware of potential subtle abnormalities and suspected the 
diagnosis upfront. Nevertheless, our study provides insight 
into the frequency of macroscopic fi ndings in CC in unselected 
patients. From this point of view, it can be argued that the 
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Table 3 Comparison of patient characteristics between centers
Center Scotland, UK 
(university)
Malmö, Sweden 
(university)
Gateshead, UK 
(district)
Tomelloso, 
Spain (district)
Chi-square test*
Total number of patients 208 203 166 5 -
Indications
Diarrhea only (%) 161 (79.3) 168 (82.8) 120 (76.4) 0 χ2=4.69
P=0.32
Diarrhea plus (%) 25 (12.3) 26 (12.8) 27 (17.2) 0
Other (%) 17 (8.4) 9 (4.4) 10 (6.4) 0
Unknown 5 0 9 5 -
Endoscopist experience
Experienced (%) 130 (62.5) 196 (96.6) 117 (70.5) 5 (100) Experienced vs 
others:
χ2=71.0
P<0.05
(signifi cant 
diff erences between 
all 3 centers analyzed)
Trainee (%) 34 (16.3) 0 24 (14.5) 0
Nurse endoscopist (%) 44 (21.2) 7 (3.4) 18 (10.8) 0
Analgesia and/or sedation given
No medication (%) 22 (10.6) 141 (69.5) 118 (71.1) 0
Analgesia or sedation given 
(%)
186 (89.4) 62 (30.5) 48 (28.9) 5 (100) Χ2=189.3
P<0.05
(signifi cance from 
Edinburgh)
Midazolam (%) 174 (83.7) 52 (25.6) 39 (23.5) 0 -
Ketobemidone (%) 0 52 (25.6) 2 (1.2) 0 -
Pethidine (%) 0 0 5 (3.0) 0 -
Fentanyl (%) 177 (85.1) 0 1 (0.6) 0 -
Entonox (%) 0 0 6 (3.6) 0 -
Buscopan (%) 8 (3.8) 10 (4.9) 21 (12.7) 0 -
Morphine (%) 0 5 (2.5) 0 0 -
General anesthesia/ propofol 
(%)
0 3 (1.5) 1 (0.6) 5 (100) -
Quality of bowel preparation
Poor (%) 21 (10.1) 3 (3.6) 2 (3.2) 0 Χ2=128.5
P<0.05
(signifi cant 
diff erences between 
all 3 centers analyzed)
Satisfactory (%) 78 (37.5) 6 (7.1) 60 (95.2) 0
Good (%) 109 (52.4) 75 (89.3) 1 (1.6) 0
Unknown 0 119 103 5 -
Colonoscopy fi ndings
No macroscopic fi ndings (%) 183 (88.0) 153 (75.4) 140 (84.3) 5 (100) Findings vs no 
fi ndings:
χ2=11.9
P<0.05
(signifi cant 
diff erences between 
all 3 centers analyzed)
University vs district 
hospitals:
χ2=0.55
P=0.46
Mucosal erythema/edema (%) 16 (7.7) 49 (24.1) 22 (13.3) 0
Linear colonic mucosal 
defects (%)
12 (5.8) 2 (1.0) 3 (1.8) 0
Cicatricial lesions/ scarring 
(%)
2 (1.0) 1 (0.5) 1 (0.6) 0
Percentages are given as a proportion of patients where the information is known. Diarrhea plus symptoms are defined as weight loss, abdominal pain, 
bloating, fatigue, anemia and/or raised fecal calprotectin. *The chi-square tests compared only the centers from Scotland, Malmö and Gateshead, because of 
the low number of patients from Tomelloso
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present study further explores the importance of being aware 
of this phenomenon, in addition to the other fi ndings.
In conclusion, endoscopic fi ndings are recognized with 
increased frequency in patients with CC [20]. However, the 
use of new, high-defi nition videocolonoscopes allows new 
insight into this entity. Factors associated with the recognition 
of these fi ndings are associated with clinical symptoms as well 
as procedural factors.
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Summary Box
What is already known:
• Collagenous colitis (CC) is a clinical syndrome of 
chronic watery diarrhea with adverse eff ects on 
patients’ quality of life
• Th e diagnosis of CC remains reliant on histology
• Certain colonoscopic fi ndings are suggestive of CC
• Th e time lag between endoscopy and histological 
confi rmation of a diagnosis can delay initiation of 
treatment
What the new fi ndings are:
• Macroscopic fi ndings suggestive of CC occur 
independently of the type of bowel preparation 
used
• Endoscopist experience had a positive correlation 
with recognition of characteristic macroscopic 
appearances of CC
• Patients with additional symptoms other than 
diarrhea were 3 times more likely to have 
macroscopic fi ndings than patients with diarrhea 
alone
• Mucosal lacerations occurred more frequently in 
patients not given analgesia for colonoscopy
